Cosmo Pharmaceuticals NV
SIX:COPN

Watchlist Manager
Cosmo Pharmaceuticals NV Logo
Cosmo Pharmaceuticals NV
SIX:COPN
Watchlist
Price: 65 CHF Market Closed
Market Cap: 1B CHF
Have any thoughts about
Cosmo Pharmaceuticals NV?
Write Note

Cosmo Pharmaceuticals NV
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cosmo Pharmaceuticals NV
Other Operating Expenses Peer Comparison

Comparables:
PRGO
JAZZ
AVDL
G
GHRS
OVB

Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Cosmo Pharmaceuticals NV
SIX:COPN
Other Operating Expenses
€2m
CAGR 3-Years
44%
CAGR 5-Years
N/A
CAGR 10-Years
7%
Perrigo Company PLC
NYSE:PRGO
Other Operating Expenses
-$47.5m
CAGR 3-Years
N/A
CAGR 5-Years
-62%
CAGR 10-Years
N/A
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Other Operating Expenses
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Other Operating Expenses
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
GH Research PLC
NASDAQ:GHRS
Other Operating Expenses
-$238k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ovoca Bio PLC
LSE:OVB
Other Operating Expenses
-€2.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
8%

See Also

What is Cosmo Pharmaceuticals NV's Other Operating Expenses?
Other Operating Expenses
2m EUR

Based on the financial report for Jun 30, 2024, Cosmo Pharmaceuticals NV's Other Operating Expenses amounts to 2m EUR.

What is Cosmo Pharmaceuticals NV's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 10Y
7%

Over the last year, the Other Operating Expenses growth was 63%. The average annual Other Operating Expenses growth rates for Cosmo Pharmaceuticals NV have been 44% over the past three years , and 7% over the past ten years .

Back to Top